The Quantellect read.As of Nov 19, 2026, 3 active firms cover eHealth Inc: 0 rate it Buy or better, 3 sit at Neutral, and 0 rate it Sell or worse, a neutral consensus. Targets are tightly clustered, $1.75 to $2.00, so the covering firms are broadly aligned. The average target of $1.92 sits 398% above the current $0.39. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.47 next quarter toward $-0.66 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS3 active firms
Neutral
Strong Buy00%
Buy00%
Neutral3100%
Sell00%
Strong Sell00%
Based on 3 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$1.92
+397.7% upside
Average target across 3 active firms as of Nov 19, 2026 vs $0.39 current
Highest Target$2.00
Average Target$1.92
Lowest Target$1.75
Detailed analyst forecasts for EHTH
Showing 1–3 of 3 named analysts shown · 3 active firms in the rating projection
As of Nov 19, 2026, 0 of 3 active firms rate EHTH a Buy (3 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
EHTH EPS & revenue forecast
EPS · NEXT QUARTER
$-0.47
Range $-0.47 – $-0.47 · 1 analysts · -19% YoY
Next period, 1 analysts expect eHealth Inc to earn $-0.47 a share (range $-0.47 – $-0.47), versus $-0.58 a year earlier. Full-year consensus is $-1.17, growing to $-0.66 the year after.
REVENUE · NEXT QUARTER
$86.9M
Range $85.5M – $88.3M · 1 analysts · -1% YoY
Revenue is expected to reach $86.9M (range $85.5M – $88.3M), -1.3% year-over-year. Full-year consensus is $420.3M, rising to $433.1M next year.
Top analysts covering eHealth Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on EHTH.
#1
Ben Hendrix
RBC Capital · Rank #150
Neutral
$2.00+419.3% to target
Overall win rate
44%
+ Follow
#2
George Sutton
Craig-Hallum · Rank #216
Neutral
No targeton EHTH
Overall win rate
34%
+ Follow
#3
JY
Jonathan Yong
UBS
Neutral
$1.75+354.4% to target
Coverage
—
+ Follow
#4
AK
Adam Klauber
William Blair
Neutral
No targeton EHTH
Coverage
—
+ Follow
#5
George Hill
Deutsche Bank
Neutral
$3.00+679.0% to target
Coverage
—
+ Follow
EHTH stock forecast FAQ
What is EHTH's average 12-month price target?+
The 3 active firms with a live target average $1.92 for eHealth Inc over the next 12 months, ranging from a $2.00 high to a $1.75 low, as of Nov 19, 2026.
Is EHTH stock a Buy, Sell or Neutral right now?+
The current consensus is Neutral. Of the 3 active firms as of Nov 19, 2026, 0 rate it Buy or Strong Buy, 3 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for EHTH?+
The Street-high target is $2.00 (RBC Capital), and the Street-low is $1.75 (UBS). The average of all 3 active-firm targets is $1.92.
How many active Wall Street firms cover EHTH?+
3 active firms have a recognized rating on eHealth Inc as of Nov 19, 2026, and 3 active firms carry a live 12-month price target.
Who is the most accurate analyst covering EHTH?+
Among analysts who currently cover EHTH, Ben Hendrix of RBC Capital has the strongest overall Quantellect track record (Rank #150). Their current call is Neutral with a $2.00 target.
What is eHealth Inc's projected EPS for next quarter?+
The consensus estimate is $-0.47 per share (range $-0.47 – $-0.47) across 1 analysts. Full-year EPS is projected at $-1.17, rising to $-0.66 the following year.
How much revenue is eHealth Inc expected to report next quarter?+
Consensus revenue is $86.9M (range $85.5M – $88.3M). Full-year revenue is projected at $420.3M, growing to $433.1M next year.
Have analysts been upgrading or downgrading EHTH lately?+
As of Nov 19, 2026, 0 of 3 active firms rate EHTH a Buy (3 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their EHTH calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.